Technical Analysis for DGX - Quest Diagnostics Incorporated

Grade Last Price % Change Price Change
B 128.44 2.01% 2.53
DGX closed up 2.01 percent on Friday, April 19, 2024, on 1.65 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 25
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 2.01%
Down 3 Days in a Row Weakness 2.01%
Lower Bollinger Band Touch Weakness 2.01%
Oversold Stochastic Weakness 2.01%
50 DMA Resistance Bearish 1.15%

   Recent Intraday Alerts

Alert Time
Up 2% about 22 hours ago
Up 1 ATR about 22 hours ago
60 Minute Opening Range Breakout about 23 hours ago
Rose Above 50 DMA about 23 hours ago
Rose Above Previous Day's High about 23 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quest Diagnostics Incorporated Description

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business offers clinical testing services, including routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights. The Diagnostic Solutions business provides risk assessment services for the life insurance industry; clinical testing services for new drugs, vaccines, and medical devices; and clinical connectivity and data management solutions for healthcare organizations and clinicians to improve patient care and medical practice, as well as develops, manufactures, and markets diagnostics products. Its products include HemoCue, a point-of-care testing product for hemoglobin, glucose, microalbumin, and white blood cell testing; Care360 HER that allows doctors to electronically create, manage, and distribute patient encounter notes; and ChartMaxx, an electronic document management system for hospitals. The company offers its services to patients, physicians, hospitals, integrated delivery networks, health plans, employers, governmental institutions, and other commercial clinical laboratories through a network of laboratories and patient service centers. Quest Diagnostics Incorporated has a strategic alliance with Hologic, Inc. to offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health. The company was founded in 1967 and is headquartered in Madison, New Jersey.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Medicine Insurance Industry Glucose Lab Testing Diagnostic Products Document Management Healthcare Organizations Risk Assessment Hemoglobin Pathology Anatomical Pathology Medical Diagnosis Radiometer Data Management Solution Diagnostic Solutions Data Management Solutions Document Management System Pathology Services Point Of Care Testing Risk Assessment Services Sunquest Information Systems

Is DGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 145.3991
52 Week Low 117.5988
Average Volume 942,675
200-Day Moving Average 129.91
50-Day Moving Average 127.67
20-Day Moving Average 129.84
10-Day Moving Average 129.04
Average True Range 2.25
RSI (14) 48.72
ADX 18.43
+DI 20.44
-DI 20.58
Chandelier Exit (Long, 3 ATRs) 127.91
Chandelier Exit (Short, 3 ATRs) 132.18
Upper Bollinger Bands 133.94
Lower Bollinger Band 125.74
Percent B (%b) 0.33
BandWidth 6.31
MACD Line -0.18
MACD Signal Line 0.37
MACD Histogram -0.5452
Fundamentals Value
Market Cap 14.31 Billion
Num Shares 111 Million
EPS 7.49
Price-to-Earnings (P/E) Ratio 17.15
Price-to-Sales 1.53
Price-to-Book 2.24
PEG Ratio 2.91
Dividend 2.84
Dividend Yield 2.21%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 132.64
Resistance 3 (R3) 132.32 130.60 131.94
Resistance 2 (R2) 130.60 129.53 130.76 131.71
Resistance 1 (R1) 129.52 128.87 130.06 129.84 131.47
Pivot Point 127.80 127.80 128.07 127.96 127.80
Support 1 (S1) 126.72 126.73 127.26 127.04 125.41
Support 2 (S2) 125.00 126.07 125.16 125.17
Support 3 (S3) 123.92 125.00 124.94
Support 4 (S4) 124.24